跳至主要内容
临床试验/NCT06951737
NCT06951737已完成不适用

Evaluation Of The Effect Of SGLT-2 Inhibitors On Atrial Fibrillation Recurrence In Diabetic Patients

Bursa Postgraduate Hospital1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2022年10月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
120
试验地点
1
主要终点
Atrial fibrillation recurrence

研究概览

简要总结

Consecutive DCCV was performed until to achieve 120 patients in SR (60 DM patients who used SGLT-2 inhibitors and 60 DM patients who did not use SGLT-2 inhibitors). Patients defined as SGLT-2 inhibitor user group and control group. The two groups were monitored for AF recurrence on the first day, then at one, three, and six months after CV.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •patients > 18 years and < 90 years,
  • •Patient diagnosed with DM
  • •Patient underwent electrical cardioversion due to AF and was restored to sinus rhythm

排除标准

  • •patient who are not suitable for anticoagulant use,
  • •have thyroid dysfunction,
  • •glomerular filtration rate ≤ 25 ml/min/1.73 m²,
  • •patients whose sinus rhythm cannot be achieved with electrical cardioversion,
  • •malignancy patients,
  • •patients with acute or chronic inflammatory disease,
  • •patients with peripheral artery disease,
  • •patients with pacemakers,
  • •patients with advanced valve stenosis or insufficiency,
  • •patients who have had coronary bypass surgery,
  • •patients with percutaneous or surgical bioprosthesis or metallic valve surgery.

结局指标

主要结局

Atrial fibrillation recurrence

时间窗: six month

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hasan ARI

Prof Dr

Bursa Postgraduate Hospital

研究点 (1)

Loading locations...

相似试验